Proteinuria
Treatment
Market
Share, Global Trends,
Analysis, Research, Report,
Opportunities,
Segmentation and Forecast,
2016– 2026
Future Market Insights
www.futuremarketinsights.com
[email protected]
Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting
services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes,
technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends.
We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC.
Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and
Retail.
We have a global presence with delivery centers across India specializing in providing global research reports and country
research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India. We
combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for our
client.
Research
Capabilities




Customized
Research
Customized Research
Syndicated Research
Investment Research
Social Media Research
Sector Coverage





Automotive and Transportation

Electronics, Semiconductor, and ICT

Retail and Consumer Products

Industrial Automation and Equipment

Healthcare, Pharmaceuticals & Medical Devices
Subscription Information
Syndicated
Research
For detailed subscription information please contact
Investment
Research
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268
Social Media
Research
Hari. T (Sr. Manager - Global Business Development)
Email: [email protected]
Chemicals & Materials
Food and Beverages
Services and Utilities
Energy, Mining, Oil, and
Gas
Report
Description
Report Description
Proteinuria is also called as albuminuria is a condition in which urine contains abnormal
(excessive) amount of protein. It is a disease which results from damage within the kidneys. The
kidney performs filtration of waste, minerals and fluids from the blood to the urine. When
kidneys do not perform filtration properly that results an abnormal (excessive) amount of
proteins (albumin and globulin) excrete through the urine. Sign and symptom of proteinuria
includes edema present in face, arms, hands, abdomen and hypertension with foamy urine. Risk
factors for proteinuria includes, diabetes and hypertension (high blood pressure) mostly and
sometimes obesity and age over 65.
American Diabetic Association stated that people with high blood pressure and diabetes are at
high risk for developing proteinuria. Thus, increase in diabetic and hypertensive patients
worldwide are the main driving factors for the growth of proteinuria treatment market. Kidney
disease often has no early symptoms. Hence, lack of awareness among people about proteinuria
is expected to restrain the growth of global proteinuria treatment market.
Proteinuria Treatment Market: Drivers and Restraints
Types of proteinuria includes Transient and Orthostatic proteinuria. Proteinuria can be caused by
diseases not involving the kidneys, such as multiple myeloma, a cancer of the plasma cells in the
bone marrow.
Report
Description
Report Description
In diabetes, the main causes of proteinuria are high blood glucose levels over a period of years.
Pre-eclampsia, a condition which can affect pregnant women, includes very high blood pressure
and is another potential cause of protein in the urine.
Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb1486
Proteinuria Treatment Market: Segmentation
Proteinuria treatment market can be segmented on the basis of drug type, distribution channel
and geography.
Based on drug type, proteinuria treatment market can be segmented as follows:
•
ACE inhibitors (angiotensin-converting enzyme inhibitors)
•
ARBs (angiotensin receptor blockers)
•
DPP (dipeptidyl peptidase) IV inhibitors
Based on distribution channel, proteinuria treatment market can be segmented as
follows:
•
Hospitals including hospital pharmacies
•
Clinics
•
Retail Pharmacies
Report
Description
Report Description
Proteinuria Treatment Market: Overview
Proteinuria can be diagnosed by urine albumin to creatinine ratio (UACR) test, glomerular
filtration rate (GFR) test, renal ultrasound scan, and kidney biopsy test. Since proteinuria is a
symptom and not a disease itself, medical care focuses on treating the underlying condition,
such as normalizing blood pressure in people with hypertension or controlling blood sugar levels
in those with diabetes. However, drugs are even prescribed for people with diabetes and high
blood pressure.
Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1486
Proteinuria Treatment Market: Region-wise Outlook
Region wise, the global proteinuria treatment marketis classified into regions namely, North
America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and
Africa. North America dominates the global market for proteinuria treatment due to high
prevalence rate of diabetes and hypertension among North American population. Moreover,
technological advancements in diagnostic test further accentuates the market growth in this
region. Europe holds the second position in proteinuria treatment owing to its large geriatric
population base (people above 65 years of age).
Report
Description
Report Description
Asia-pacific holds the third and fourth position in the global proteinuria treatment market due
to lack of sufficient healthcare facilities (diagnostic test).
Proteinuria Treatment Market: Key Players
Some of the key players contributing to the global proteinuria treatment market includes Eli Lilly
And Company, Bristol-Myers Squibb, Merck & Co, Inc., AstraZeneca Plc., Reddys Lab, and
Novartis AG.
Thank You!
To know more about us, please visit our website:
www.futuremarketinsights.com
For sales queries or new topics email us on:
[email protected]
For other queries contact:
Future Market Insights: 616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
T: +1-347-918-3531 | D: +1-845-579-5705